Claim Missing Document
Check
Articles

Found 3 Documents
Search

Pregnancy and Covid 19 Infection: Characteristics, Signs, Symptoms, and Impact on Maternal and Neonatal: Systematic Review Purwatiningsih, Yuni; Lestyoningrum, Sinta Dewi; Wulandari, Aliesya Patricia
Jurnal Aisyah : Jurnal Ilmu Kesehatan Vol 7, No S1 (2022): Suplement 1
Publisher : Universitas Aisyah Pringsewu

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (783.699 KB) | DOI: 10.30604/jika.v7iS1.1182

Abstract

The Covid 19 pandemic had a terrible impact on the health system, especially maternal and child health. Covid 19 and MERS infections lead to higher case fatality rates and more severe morbidity during pregnancy. Pregnant women and neonates are a group at risk for the severity of Covid 19 infection. This study aimed to review the characteristics, signs, symptoms, and impact on maternal and neonatal of pregnant women with positive Covid 19. We performed a systematic review to investigate pregnant women infected with Covid 19. Literature research was conducted using several search engines, including PubMed, Science Direct, and The Lancet, from January 1st, 2021 to March 31th, 2022. The articles were screened based on the inclusion and exclusion criteria based on the PRISMA guidelines. We included 8 studies, the number of pregnant women obtained was 1460 pregnant women with positive COVID 19, 1830 pregnant women with negative COVID-19, and 71 nonpregnant women with positive Covid 19. The average age of the mother is around 19-41 years, gestational age is between 25-41 weeks, and the common symptoms are fever, cough, difficulty breathing, or shortness of breath. The most common complications were premature birth and premature rupture of membranes; besides bleeding complications, preeclampsia and fetal distress were reported. The common symptoms are fever and cough, and the impact of maternal are preterm birth and premature rupture of the membranes. The effect of neonatal is low birth weight and premature.  Abstrak: Pandemi Covid 19 memberikan dampak yang sangat buruk bagi sistem kesehatan, khususnya untuk kesehatan ibu dan anak. Infeksi Covid 19 dan MERS menyebabkan tingkat kematian kasus yang lebih tinggi dan tingkat morbiditas yang lebih parah selama kehamilan. Ibu hamil dan neonatus merupakan kelompok yang berisiko untuk terjadinya infeksi Covid-19 yang berat. Penelitian ini bertujuan untuk mengkaji karakteristik, tanda, gejala, dan dampak pada ibu dan bayi baru lahir dari ibu hamil yang positif Covid 19. Penelitian merupakan systematic review yang dilakukan untuk menyelidiki ibu hamil yang terinfeksi Covid 19. Penelitian ini dilakukan dengan melakukan pencarian literatur menggunakan beberapa database pencarian elektronik , antara lain PubMed, Science Direct, dan The Lancet  yang dipublikasi pada satu tahun terakhir yaitu mulai 1 Januari 2021 dan 31 Maret 2022. Artikel yang diperoleh dilakukan screening berdasarkan kriteria inklusi dan eksklusi berdasarkan pedoman PRISMA. Terdapat 8 artikel penelitian yang kami masukkan kedalam penelitian ini yang telah sesuai dengan kriteria inklusi, jumlah ibu hamil yang didapat adalah 1460 ibu hamil positif COVID 19 dan 1830 ibu hamil negatif COVID-19. Rata-rata usia ibu sekitar 19-41 tahun, usia kehamilan antara 25-41 minggu, dan gejala yang umum adalah demam, batuk, sulit bernapas, atau sesak napas. Komplikasi yang paling umum adalah kelahiran prematur dan ketuban pecah dini, selain dari komplikasi perdarahan, preeklamsia dan gawat janin juga dilaporkan. Gejala yang umum adalah demam dan batuk, dan dampak dari ibu adalah kelahiran prematur dan ketuban pecah dini. Efek neonatus adalah berat badan lahir rendah dan prematur.
Maternal death causes before and during COVID-19 pandemic: a descriptive study in Banjarnegara Indonesia Purwatiningsih, Yuni; Sunaryo; Lestyoningrum, Sinta Dewi
BKM Public Health and Community Medicine Vol 39 No 01 (2023)
Publisher : Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/bkm.v39i01.6260

Abstract

Purpose: Maternal mortality in Indonesia in 2017 was 3rd highest in Southeast Asia. The Banjarnegara District in 2018 was ranked with the third highest maternal mortality rate in Central Java Province. In previous years, the most common cause of maternal death in the district was bleeding, but in 2021 the biggest cause was COVID-19. This study aims to examine cases of maternal mortality by analyzing maternal characteristics, causes, and health service coverage from 2019 to 2021. Methods: The design of this study is a descriptive epidemiological study of maternal death cases in Banjarnegara in 2019-2021 using secondary data from the district health office. In-depth interviews with health workers in the public health center and the district health office. Results: Maternal death cases in 2019-2021 were 81 cases. COVID-19 will be the leading cause of maternal death during the COVID-19 pandemic in 2021, accounting for 60%. Conclusion: Preeclampsia was the leading cause of maternal death before the COVID-19 pandemic, while COVID-19 infection emerged as the primary cause in 2021. Strategic measures are needed to increase access to well-coordinated health services to reduce maternal deaths related to COVID-19 and the other effects of the pandemic.
THE COST OF TREATMENT FOR PEDIATRIC TUBERCULOSIS PATIENTS: A CROSS-SECTIONAL STUDY Lestyoningrum, Sinta Dewi; Noveyani, Adistha Eka; Putro, Wahyu Gito; Faisal, Debri Riski; Purwatiningsih, Yuni; Mikrajab, Muhammad Agus; Nugraheni, Wahyu Pudji
Indonesian Journal of Health Administration (Jurnal Administrasi Kesehatan Indonesia) Vol. 13 No. 2 (2025): Article in Press
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: Tuberculosis (TB) is a leading global communicable disease. Pediatric tuberculosis, in particular, is prevalent among the population aged 0-14 years and necessitates a treatment duration of at least six months. Aims: This study aims to assess the total treatment cost of pediatric tuberculosis patients and determine the factors associated with the total cost. Methods: A cross-sectional design was employed to collect the retrospective data at a public hospital and PHC in the province-level Special Region of Yogyakarta, Indonesia. Treatment costs are categorized into the following: laboratory costs, professional costs, drug costs, medical and non-medical support costs, and miscellaneous costs. The collected data underwent both descriptive and statistical analysis using regression methods, namely logistic and probit regressions. Results: The analysis revealed that most patients were between 0 and 2 years old and most of them are school-age, with an average treatment cost of USD 62.80 per patient. The study identified laboratory costs (RR 0.198; 95% CI 0.083-0.314), professional costs (RR 9.402; 95% CI 4.108-14.698), drug costs (RR 5.269; 95% CI 2.326-8.212), and medical support costs (RR 0.223;95% CI 0.064-0.382) as the primary contributors to the total cost. Conclusion: The point of this study is that effective treatment is possible with proper financial support. To achieve a successful outcome in treating pediatric tuberculosis, it is imperative to establish an advocacy and collaboration effort to enhance the primary health services. This cooperative effort should prioritize convenient access to treatment and enhancing active case finding. Keywords: cost of illness, cost of treatment, pediatric tuberculosis